---
title: "Yunding Tech released its 2024 annual performance, with a net profit attributable to the parent company of 92.7435 million yuan, a year-on-year increase of 50.11%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235007750.md"
description: "Yunding Tech released its 2024 annual report, with operating revenue of 1.351 billion yuan, a year-on-year increase of 18.35%; net profit attributable to the parent company was 92.7435 million yuan, a year-on-year increase of 50.11%; net profit excluding non-recurring gains and losses was 74.504 million yuan, a year-on-year increase of 25.04%; basic earnings per share were 0.1396 yuan"
datetime: "2025-04-08T11:24:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235007750.md)
  - [en](https://longbridge.com/en/news/235007750.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235007750.md)
generator: "portal-rs"
---

# Yunding Tech released its 2024 annual performance, with a net profit attributable to the parent company of 92.7435 million yuan, a year-on-year increase of 50.11%

According to the Zhitong Finance APP, Yunding Tech (000409.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 1.351 billion yuan, a year-on-year increase of 18.35%. The net profit attributable to shareholders of the listed company was 92.7435 million yuan, a year-on-year increase of 50.11%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 74.504 million yuan, a year-on-year increase of 25.04%. The basic earnings per share were 0.1396 yuan

### Related Stocks

- [000409.CN](https://longbridge.com/en/quote/000409.CN.md)

## Related News & Research

- [Church's Texas Chicken's China debut drew 2-hour lines — and $22 offers to wait in them](https://longbridge.com/en/news/297600833.md)
- [Denmark sends conscripts to Greenland as Arctic tensions grow](https://longbridge.com/en/news/297744144.md)
- [India's state-backed infra fund secures $2 bln commitment from global, local investors](https://longbridge.com/en/news/297478396.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [XesGalicia-backed Vig-Sec Drone joins NATO DIANA accelerator program](https://longbridge.com/en/news/297809767.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**